Parallel Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
PAM
WA
NC
RHJA
Parallel Advisors's ATRC Position: Q2 2026 in Review
Parallel Advisors reduced its AtriCure (ATRC) stake by 0.96% in Q2 2026, selling an estimated $985 and leaving 3,608 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.
Parallel Advisors first reported a position in ATRC in Q3 2019 and has held it in 28 quarters since. The position peaked at $316K in Q2 2021. 78 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Parallel Advisors held 3,608 shares of AtriCure worth $101K as of Q2 2026.
- Parallel Advisors sold 35 AtriCure shares in Q2 2026, an estimated $985.
- AtriCure made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1704 holding.
- Parallel Advisors first reported a position in AtriCure in Q3 2019 and has held it in 28 quarters since.
- Parallel Advisors's AtriCure position peaked at $316K in Q2 2021.
- 78 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.